{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:05:53Z","timestamp":1793505953402,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107931","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:03:57Z","timestamp":1625807037000},"page":"107931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6\/\u0392-catenin signaling and enhancement of BSEP and MDRP2 expression"],"prefix":"10.1016","volume":"99","author":[{"given":"Entsar A.","family":"Nazmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar G.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5529-6994","authenticated-orcid":false,"given":"Eman","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107931_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jiec.2017.07.018","article-title":"Synthetic polyphenol compounds inhibit \u03b2-catenin\/Tcf signaling: Structure-activity relationship","volume":"56","author":"Ahn","year":"2017","journal-title":"J. Ind. Eng. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2021.107931_b0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5455\/msm.2016.28.454-458","article-title":"Open Clinical Trial on Using Nifuroxazide Compared to Probiotics in Treating Acute Diarrhoeas in Adults","volume":"28","author":"Begovic","year":"2016","journal-title":"Materia Socio Medica"},{"issue":"5","key":"10.1016\/j.intimp.2021.107931_b0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.108.023317","article-title":"Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-Induced liver injury in mice","volume":"37","author":"Beilke","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107931_b0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2021.107931_b0025","first-page":"71","article-title":"Bile acid metabolism in liver pathobiology","author":"Chiang","year":"2018","journal-title":"Gene Expr.. Cognizant Communication Corporation"},{"key":"10.1016\/j.intimp.2021.107931_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115976","article-title":"Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study","volume":"31","author":"El-Khouly","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107931_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107396","article-title":"Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy","author":"Goossens","year":"2019","journal-title":"Pharmacol. Therap."},{"issue":"3","key":"10.1016\/j.intimp.2021.107931_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00383-012-3225-0","article-title":"Higher expression of phosphorylated myosin regulatory light chain in the common bile duct in pancreaticobiliary maljunction accompanied by bile duct dilatation in children: A post-mortem observational study","volume":"29","author":"Guo","year":"2013","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.intimp.2021.107931_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119241","article-title":"Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3\/NF-\u03baB signaling, oxidative stress and inflammation","volume":"272","author":"Hassan","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107931_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1248\/bpb.b16-00529","article-title":"Ursodeoxycholic acid ameliorates intrahepatic cholestasis independent of biliary bicarbonate secretion in vil2kd\/kd mice","volume":"40","author":"Hatano","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2021.107931_b0055","doi-asserted-by":"crossref","DOI":"10.1007\/s11356-021-12716-0","article-title":"Graviola mitigates acetic acid\u2013induced ulcerative colitis in rats: insight on apoptosis and Wnt\/Hh signaling crosstalk","author":"Helal","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"5","key":"10.1016\/j.intimp.2021.107931_b0060","first-page":"1100","article-title":"Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4-induced cirrhosis: Protective role of adenosine administration","volume":"26","author":"Hern\u00e1ndez-Mu\u00f1oz","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.107931_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver-from homeostasis to disease","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2021.107931_b0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile-acid: Relevance to drug hepatotoxicity","author":"Hofmann","year":"2004","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107931_b0075","first-page":"48","article-title":"Effect of nifuroxazide on proliferation, migration, and invasion of thyroid papillary carcinoma cells","volume":"50","author":"Hu","year":"2019","journal-title":"J. Sichuan Univ. (Med. Sci. Ed.)"},{"issue":"10","key":"10.1016\/j.intimp.2021.107931_b0080","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/labinvest.2009.82","article-title":"Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling","volume":"89","author":"Huang","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2021.107931_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117610","article-title":"Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK\/caspase-8\/TRAIL activation in rats","volume":"252","author":"Khodir","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2021.107931_b0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107931_b0095","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","article-title":"Primary biliary cirrhosis - Presentation and diagnosis","author":"Leuschner","year":"2003","journal-title":"Clin. Liver Dis."},{"issue":"8\u20139","key":"10.1016\/j.intimp.2021.107931_b0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.prp.2005.06.004","article-title":"Cholangitis: A histologic classification based on patterns of injury in liver biopsies","volume":"201","author":"Li","year":"2005","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.intimp.2021.107931_b0105","doi-asserted-by":"crossref","unstructured":"I.-Y. Lin, et al., CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-b, Wnt and STAT3 signaling pathways, 2018. http:\/\/dx.doi.10.1016\/j.jfda.2018.09.008.","DOI":"10.1016\/j.jfda.2018.09.008"},{"issue":"4","key":"10.1016\/j.intimp.2021.107931_b0110","doi-asserted-by":"crossref","DOI":"10.1139\/cjpp-2016-0447","article-title":"Sulforaphane protects against sodium valproate\u2013induced acute liver injury","volume":"95","author":"Nazmy","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107931_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103240","article-title":"Targeting p53\/TRAIL\/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats","volume":"72","author":"Nazmy","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107931_b0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcp.2019.06.009","article-title":"Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis","volume":"168","author":"Razori","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107931_b0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2017.12.030","article-title":"Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats","volume":"281","author":"Said","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.intimp.2021.107931_b0130","first-page":"32","article-title":"Nifuroxazide-induced acute pancreatitis: A new side-effect for an old drug?","volume":"70","author":"Shindano","year":"2007","journal-title":"Acta Gastro-Enterologica Belgica"},{"issue":"3","key":"10.1016\/j.intimp.2021.107931_b0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.29371","article-title":"\u03b2-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis","volume":"67","author":"Thompson","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.107931_b0140","doi-asserted-by":"crossref","unstructured":"S. Tremblay, et al., Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection, 2017. Available at: https:\/\/doi.org\/10 (Accessed: 13 January 2021).","DOI":"10.1128\/IAI.00942-16"},{"key":"10.1016\/j.intimp.2021.107931_b0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-010818-021059","article-title":"Drug Therapies for Chronic Cholestatic Liver Diseases","author":"Wagner","year":"2020","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2021.107931_b0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41422-020-0302-0","article-title":"Cryo-EM structure of human bile salts exporter ABCB11","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"MAY","key":"10.1016\/j.intimp.2021.107931_b0155","article-title":"Emodin rescues intrahepatic cholestasis via stimulating FXR\/BSEP pathway in promoting the canalicular export of accumulated bile","volume":"10","author":"Xiong","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107931_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.63","article-title":"Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2021.107931_b0165","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: New and unexpected biological functions","author":"Yu","year":"2014","journal-title":"Nature Rev. Cancer"},{"issue":"35","key":"10.1016\/j.intimp.2021.107931_b0170","doi-asserted-by":"crossref","first-page":"31441","DOI":"10.1074\/jbc.M200474200","article-title":"Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2021.107931_b0175","article-title":"Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:09Z","timestamp":1730837589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"alternative-id":["S1567576921005671"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107931","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6\/\u0392-catenin signaling and enhancement of BSEP and MDRP2 expression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107931"}}